Physician profile
Pierre M Johnson
NPI 1659531903
$359,554.04
in general payments reported to CMS, 2019-2025
21 companies · $31K in 2025
The $31K reported for 2025 was more than what 98% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $4,508 · 2021: $85K · 2022: $147K · 2023: $59K · 2024: $33K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $105K · Travel and Lodging: $13K · Food and Beverage: $3,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $105,299.58 |
| Travel and Lodging | $13,353.74 |
| Food and Beverage | $3,914.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $316,353.97 | 2019-2025 | Acessa Provu System |
| Intuitive Surgical, INC. | $30,197.32 | 2019-2025 | |
| Hologic Sales and Service, LLC | $10,051.98 | 2021-2025 | Acessa Provu System, Coolseal Generator, Myosure Tissue Removal Device |
| Cytyc Surgical Products, LLC | $1,159.56 | 2023-2025 | Acessa Provu System |
| Abbvie INC. | $467.94 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $440.94 | 2023-2025 | Myfembree |
| Agile Therapeutics, INC. | $199.18 | 2021 | |
| Conmed Corporation | $174.35 | 2023 | Vcare |
| Aspira Women'S Health INC | $123.23 | 2021-2022 | |
| Myovant Sciences INC. | $82.58 | 2021-2022 | |
| Abiomed | $45.25 | 2025 | |
| Avion Pharmaceuticals | $42.86 | 2021 | |
| Therapeuticsmd, INC. | $40.95 | 2020-2022 | |
| Novo Nordisk INC | $33.09 | 2020 | |
| Hologic INC | $33.03 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20.43 | 2019 | |
| Gynesonics, INC. | $18.76 | 2021 | |
| Lupin INC. | $18.47 | 2020 | |
| Minerva Surgical, INC | $17.61 | 2021 | |
| Ethicon US, LLC | $16.88 | 2023 | Echelon Flex |
| Nevro Corp. | $15.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pierre Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.